DHA OMNIBUS IV Military Medical Research and Development

CONTRACT OVERVIEW

WTI was awarded a prime position on the DHA OMNIBUS IV Military Medical Research and Development Contract. This is an indefinite delivery/indefinite quantity (IDIQ), multiple-award contract with a ceiling value of $10 billion.

The Department of Defense has an on-going need for discovery and integration of innovative medical knowledge and material solutions to continually enhance Force health readiness, resilience and rehabilitation. OMNIBUS IV is designed to enhance the related medical research and development programs of the Department of Defense.

The OMNIBUS IV requirement provides for a broad range of health-related research and development and support services that are separated into four Market Segments:

Research and Development (R&D)
R&D Support Services
Regulatory Processes
Translational Science Support and Services

For more information, email [email protected]

Corporate Summary

WTI is a CMMI® Level 3 appraised Women-Owned Small Business (WOSB) based in the National Capital Region, committed to helping the government and industry harness the power of actionable information through intelligence and IT solutions.